CBT-002

N/A

Report date: 2025/11/20 16:04:57

Base Information

Drug NameCBT-002

Drug Alias NameCBT-002

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug ConjugatesSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)

Mechanisms of ActionSomatostatin receptor 2 modulators

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesC-Biomex Ltd

China Registration ClassN/A

Develop Information

Active CompaniesC-Biomex Ltd

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A